While these deals strengthen Palo Alto's positioning in the cybersecurity space and expand on its platformization strategy, ...

Costco stock is up 15% year to date after a strong January sales report. The stock is trading at a high price-to-earnings multiple of 53, raising concerns about its valuation. Despite strong digital ...

Net stock sales by institutional investors for the week ending Feb. 13 were the second-highest on record. Even though institutional investor skepticism is rising, patience has historically paid off ...

Even with all that, Keytruda's empire, although weakened, should remain strong until the next decade. Merck has received approval for a subcutaneous formulation of the medicine, which has significant ...

Tilray Brands (TLRY 1.65%) bills itself as "a global lifestyle and consumer packaged goods company leading at the nexus of the beverage, cannabis, and wellness industries." While ...

Enbridge ( ENB 0.21%) has an elite track record. The Canadian pipeline and utility company has increased its dividend for 31 ...

Through 2030, ExxonMobil expects double-digit earnings and cash flow growth, even at mediocre oil prices. Relentless buybacks ...

Novartis ( NVS 0.66%) is a major Swiss drug company with a market capitalization of over $300 billion. Its focus areas are ...

Drugmakers Novo Nordisk and Eli Lilly are battling it out in the GLP-1 weight loss market. The pill version of Novo Nordisk's ...

The ProShares UltraShort Financials ETF ratchets up bearish bets on a popular sector. It's been nearly two decades since the Global Financial Crisis sparked a wave of bank failures, casting a dark ...

There are several solid prospects to choose from right now, but there's a reason I can't get these particular names out of my ...

Johnson & Johnson ( JNJ 1.87%) is a legend among dividend investors. It's a Dividend King, meaning it has paid and raised its ...